MedPath

A Prospective Observational Study on the Effectiveness and Safety of Korean Medicine Treatment Based on the Standard Clinical Practice Guidelines in Patients with Acute Facial Palsy

Not Applicable
Conditions
Certain infectious and parasitic diseases
Registration Number
KCT0006562
Lead Sponsor
Kyung Hee University Oriental Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
73
Inclusion Criteria

1. Among outpatients with facial palsy who has visited the research institution for the first time, the patients whose primary diagnosis is facial palsy(G51.0-bell palsy, G51.8-detailed facial neuropathy, G51.9-facial nerve damage, B022-lamsayhunt syndrome) after the treatment
2. Patients with facial palsy which occurred within 7 days
3. Adult patients who are over the age of 19, and who has decided to participate in the study of their own will or their legal representative's will and signed the consent form.

Exclusion Criteria

1. Patients participating in other clinical studies (not applicable to those participating in observational studies)
2. Patients with a history of facial palsy
3. Patients with bilateral facial palsy
4. Patients receiving Korean medicine treatment through other Korean medicine clinics or Korean medicine hospitals
5. Patients who are expected to have difficulty adapting to clinical research schedules
6. Patients who are expected to have difficulty understanding and responding to research questionnaires such as illiteracy and mental and physical weaknesses
7. Patients who are determined by researchers that they are unable to participate in the study

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
House-Brackmann grading system, Measurement of eyebrow and lip movement, Pre-occurrence symptoms and accompanying symptoms related to facial palsy
Secondary Outcome Measures
NameTimeMethod
Facial Disability Index(FDI), EQ-5d-5l, EQ-VAS;Was it Worth it (WIWI) questionnaire
© Copyright 2025. All Rights Reserved by MedPath